Oncoprotein EWS-FLI1 activity is enhanced by RNA helicase A

JA Toretsky, V Erkizan, A Levenson, OD Abaan… - Cancer research, 2006 - AACR
JA Toretsky, V Erkizan, A Levenson, OD Abaan, JD Parvin, TP Cripe, AM Rice, SB Lee
Cancer research, 2006AACR
Abstract RNA helicase A (RHA), a member of the DEXH box helicase family of proteins, is an
integral component of protein complexes that regulate transcription and splicing. The EWS-
FLI1 oncoprotein is expressed as a result of the chromosomal translocation t (11; 22) that
occurs in patients with the Ewing's sarcoma family of tumors (ESFT). Using phage display
library screening, we identified an EWS-FLI1 binding peptide containing homology to RHA.
ESFT cell lines and patient tumors highly expressed RHA. GST pull-down and ELISA assays …
Abstract
RNA helicase A (RHA), a member of the DEXH box helicase family of proteins, is an integral component of protein complexes that regulate transcription and splicing. The EWS-FLI1 oncoprotein is expressed as a result of the chromosomal translocation t(11;22) that occurs in patients with the Ewing's sarcoma family of tumors (ESFT). Using phage display library screening, we identified an EWS-FLI1 binding peptide containing homology to RHA. ESFT cell lines and patient tumors highly expressed RHA. GST pull-down and ELISA assays showed that EWS-FLI1 specifically bound RHA fragment amino acids 630 to 1020, which contains the peptide region discovered by phage display. Endogenous RHA was identified in a protein complex with EWS-FLI1 in ESFT cell lines. Chromatin immunoprecipitation experiments showed both EWS-FLI1 and RHA bound to EWS-FLI1 target gene promoters. RHA stimulated the transcriptional activity of EWS-FLI1 regulated promoters, including Id2, in ESFT cells. In addition, RHA expression in mouse embryonic fibroblast cells stably transfected with EWS-FLI1 enhanced the anchorage-independent phenotype above that with EWS-FLI1 alone. These results suggest that RHA interacts with EWS-FLI1 as a transcriptional cofactor to enhance its function. (Cancer Res 2006; 66(11): 5574-81)
AACR